ICON has extensive experience in conducting gastrointestinal studies

We work across the across the entire drug development spectrum. Our experience ranges from the initial studies in Phase I through post-marketing efforts in Phase IV.

ICON gastrointestinal experience in last five years

  • 110+

    Clinical gastrointestinal studies
  • 18,500+

    Patients
  • 6,696

    Sites worldwide

ICON's Gastrointestinal Center of Excellence

ICON's Gastrointestinal Center of Excellence has dedicated drug development experts with significant experience conducting clinical trials for experimental therapeutics in the following diseases:

Acid Reflux

Chronic Functional Constipation

Indigestion

Acute Gastric Pain

Crohn’s Disease

Idiopathic Gastroparesis

Acute Pancreatitis

Diarrhea

Inflammatory Bowel Disease

Bowel Prep

Diverticulitis

Irritable Bowel Syndrome

Celiac

Dyspepsia

Irritable Bowel Syndrome with Constipation

Chronic Constipation

Eosinophilic Esophagitis

Irritable Bowel Syndrome with Diarrhea

Colorectal Conditions

Esophagitis

Short Bowel Syndrome

Constipation

Gastroesophageal Reflux

Traveler's Diarrhea

Chronic Idiopathic Constipation
 

GERD

Ulcerative Colitis

ICON has the expertise to support GI clinical studies from initial strategy development through pricing and market access recommendations. Contact us to learn more.